全反式维甲酸与奥沙利铂在诱导人胃癌BGC-823细胞凋亡中的协同作用
|
摘要
胃癌是常见的恶性肿瘤,在世界范围内最常见的恶性肿瘤中占第4位,死亡率占所有恶性肿瘤的第2位。在我国胃癌发病率和死亡率分别占恶性肿瘤的第1位和第3位。针对胃癌的治疗药物也层出不穷,短期内显示出良好的临床疗效。然而大规模的随访研究结果表明,肿瘤患者的远期生存率并没有因为化疗药物的使用而得到显著提高,而且有些化疗药物严重的毒副作用限制了它们在临床上的应用。探索低剂量多药联合应用,是肿瘤药物研究的一个重要方向。
全反式维甲酸(all-trans retinoic acid, ATRA)是维生素A的主要代谢产物,是维持生长发育不可缺少的物质,是一种公认的诱导分化剂。奥沙利铂(Oxaliplatin, L-OHP)是第三代铂类抗癌化合物,主要用于晚期大肠癌的治疗。由于其与第一代顺铂和第二代卡铂均无交叉耐药性,并且耐受性好、毒副作用小,因而受到广泛重视。
ATRA与L-OHP联合作用于胃癌是否能够提高疗效,目前未见报道。本实验从体外细胞学角度观察全反式维甲酸(ATRA)与奥沙利铂(L-OHP)对人胃癌BGC-823细胞凋亡的诱导作用,从而为进一步研究提供理论基础。
1.用ATRA和L-OHP单独及联合作用于BGC-823细胞,倒置显微镜下观察细胞形态变化；
2.采用MTT法检测ATRA及L-OHP分别作用24h、48h、72h后BGC-823细胞的增殖抑制率；
3.采用流式细胞仪检测ATRA及L-OHP作用48h后BGC-823细胞的凋亡率及周期变化；
4.采用免疫细胞化学技术检测ATRA及L-OHP作用48h后BGC-823细胞中Bcl-2和Survivin蛋白的表达情况。
1.药物作用24h后,细胞间隙增宽,胞内颗粒增多,出现空泡；作用48h后,多数细胞漂浮于培养液中,少量细胞仍贴壁生长,并可见部分细胞的细胞核固缩、断裂成碎片、核膜消失,细胞膜完整且有突起,呈凋亡晚期改变；作用72h后,凋亡细胞数量逐渐增多。随着作用时间的延长,与对照组相比,实验组细胞碎片数量明显增多,贴壁细胞数量显著减少。
2. ATRA对BGC-823细胞的抑制作用呈现时间依赖性,24h后对细胞的抑制作用不显著,48h和72h后抑制作用相对明显,与对照组相比差异有统计学意义(P<0.05)。联合用药后抑制作用更加显著,与ATRA组及L-OHP组相比差异有统计学意义(P<0.05),最佳作用时间为加药后48h。
3. ATRA作用细胞后,G0/G1期和G2/M期的细胞比率增加,S期的细胞比率下降；L-OHP作用细胞后,G0/G1期的细胞比率下降,S期和G2/M期的细胞比率增加；联合用药后G0/G1期和G2/M期的细胞比率增加,S期的细胞比率下降；联合用药组与ATRA组、L-OHP组相比,凋亡率差异均有统计学意义(P<0.05)。
4.对照组中可以见到细胞质中较多的Survivin蛋白和Bcl-2蛋白表达,呈浅黄色到棕黄色颗粒。ATRA组和L-OHP组阳性表达细胞数减少,而联合用药组的细胞表达数更少。联合用药组与ATRA组、L-OHP组相比,蛋白阳性率差异均有统计学意义(P<0.05)。
1. ATRA对人胃癌BGC-823细胞存在增殖抑制作用,且具有时间依赖性,最佳作用时间为48h,与L-OHP联用后对BGC-823细胞的增殖抑制作用更显著。
2. ATRA可诱导人胃癌BGC-823细胞分化,形成G0/G1期阻滞；L-OHP可促进细胞凋亡,形成G2/M期和S期阻滞。两者联用可发挥协同作用,加强对BGC-823细胞凋亡的促进作用。
3. ATRA与L-OHP可诱导人胃癌BGC-823细胞凋亡,机制可能与下调Bcl-2蛋白和Survivin蛋白的表达有关。
Gastric cancer is a common malignancy worldwide, accounts for the forth most common malignant tumors and the first two of the total cancer death rate. In our country,the incidence and mortality of gastric cancer account for the first 1 and 3 respectly. Medicines for the treatment of gastric cancer emerging in the short term showed good clinical efficacy. However, large-scale follow-up show that long-term survival of cancer patients has not increased significantly as the use of chemotherapy and serious side effects of some chemotherapy drugs limit their clinical application. Low-dose and multi-drug combinatioand is an important cancer drug research direction.
All-trans retinoic acid (all-trans retinoic acid, ATRA) is the major metabolite of vitamin A,and is essential to maintain growth and development.It is a recognized differentiation inducer. Oxaliplatin (Oxaliplatin, L-OHP) is the third generation platinum anti-cancer compounds, mainly used for advanced colorectal cancer. It has no cross-resistance with the first generation cisplatin and the second generation carboplatin and its good tolerance, low toxicity, therefore it is recognized.
Whether ATRA combined with L-OHP used in gastric cancer can increase efficacy has currently not reported. In this study, we observe the induction of apoptosis of retinoic acid (ATRA) comibined with oxaliplatin (L-OHP) in human gastric cancer BGC-823 cells in vitro observation of cellular, thus provide a theoretical basis for further study.
1. Treat BGC-823 cells with ATRA、L-OHP respectively and then combined, observe the morphologieal changes of BGC-823 cells by inverted microscope.
2. Assesse the proliferative inhibition rate of BGC-823 cells after treated with ATRA and L-OHP respectively for 24h,48h,72h by MTT assay.
3. Analyze the changes of apoptosis rate and cell cycle of BGC-823 cells after treated with ATRA and L-OHP for 48h by flow cytometry(FCM).
4. Detect the expressions of Bcl-2 and Survivin protein of BGC-823 cells after treated with ATRA and L-OHP for 48h by immunohistochemistry method.
1.24h after treated with drugs, cell gaps widened, intracellular granules increased and became vacuoles.48h later,most of cells floated in the culture medium and few cells still shew adherent growth. The nucleus in some cells were pyknosis and broken.The nuclear membrane disappeard but the cell membrane kept integrity and grew apophysises.All of the changes shew the advanced stage of apoptotisis.72h later, the number of apoptotic cells increased.Compared with the control group,more cells became debris and the number of adherent cells reduced significantly in experimental groups.
2. The proliferative inhibition effect of the cells treated with ATRA shew time dependence and the effect was not obvious at 24h.48h and 72h later,the effect was relatively obvious.Compared with the control group,the difference was statistically significant(P<0.05).The inhibition effect was more significant in the combined group. The best time of action was 48h.Compared with the ATRA group and L-OHP group,the difference was statistically significant(P<0.05).
3.48h after treated with ATRA, the rate of G0/G1 and G2/M phase cellls increased and the rate of S phase decreased. After treated with L-OHP, the rate of G0/G1 phase declined, while phase S and G2/M increased.In the combined group, the rate of G0/G1 phase and G2/M phase cells increased and S phase decreased. The differences of the apoptosis rate among the three groups was statistically significant(P<0.05).
4. Among the four groups,the expression of Survivin protein and Bcl-2 protein in cytoplasm were the most in the control group and the least in the combined group.The differences of the positive rate among the four groups was statistically significant (P<0.05).
1. ATRA could inhibit the proliferation of human gastric cancer BGC-823 cells and the effect shew time dependence.The best results appeared at 48h. Associated with L-OHP, the proliferative inhibition effect of the cells reinforced.
2. ATRA could induce the differentiation of human gastric cancer BGC-823 cells and arouse G0/G1 phase arrest.L-OHP could promote cell apoptosis and arouse G2/M phase and S phase arrest.The effect of inducing apoptosis were enhanced when ATRA and L-OHP were combined.
3. ATRA and L-OHP could induce the apoptosis of human gastric cancer BGC-823 cells and the probable mechanism might be related to the down regulation of the expression of Bcl-2 and Survivin protein.
全反式维甲酸(all-trans retinoic acid, ATRA)是维生素A的主要代谢产物,是维持生长发育不可缺少的物质,是一种公认的诱导分化剂。奥沙利铂(Oxaliplatin, L-OHP)是第三代铂类抗癌化合物,主要用于晚期大肠癌的治疗。由于其与第一代顺铂和第二代卡铂均无交叉耐药性,并且耐受性好、毒副作用小,因而受到广泛重视。
ATRA与L-OHP联合作用于胃癌是否能够提高疗效,目前未见报道。本实验从体外细胞学角度观察全反式维甲酸(ATRA)与奥沙利铂(L-OHP)对人胃癌BGC-823细胞凋亡的诱导作用,从而为进一步研究提供理论基础。
1.用ATRA和L-OHP单独及联合作用于BGC-823细胞,倒置显微镜下观察细胞形态变化；
2.采用MTT法检测ATRA及L-OHP分别作用24h、48h、72h后BGC-823细胞的增殖抑制率；
3.采用流式细胞仪检测ATRA及L-OHP作用48h后BGC-823细胞的凋亡率及周期变化；
4.采用免疫细胞化学技术检测ATRA及L-OHP作用48h后BGC-823细胞中Bcl-2和Survivin蛋白的表达情况。
1.药物作用24h后,细胞间隙增宽,胞内颗粒增多,出现空泡；作用48h后,多数细胞漂浮于培养液中,少量细胞仍贴壁生长,并可见部分细胞的细胞核固缩、断裂成碎片、核膜消失,细胞膜完整且有突起,呈凋亡晚期改变；作用72h后,凋亡细胞数量逐渐增多。随着作用时间的延长,与对照组相比,实验组细胞碎片数量明显增多,贴壁细胞数量显著减少。
2. ATRA对BGC-823细胞的抑制作用呈现时间依赖性,24h后对细胞的抑制作用不显著,48h和72h后抑制作用相对明显,与对照组相比差异有统计学意义(P<0.05)。联合用药后抑制作用更加显著,与ATRA组及L-OHP组相比差异有统计学意义(P<0.05),最佳作用时间为加药后48h。
3. ATRA作用细胞后,G0/G1期和G2/M期的细胞比率增加,S期的细胞比率下降；L-OHP作用细胞后,G0/G1期的细胞比率下降,S期和G2/M期的细胞比率增加；联合用药后G0/G1期和G2/M期的细胞比率增加,S期的细胞比率下降；联合用药组与ATRA组、L-OHP组相比,凋亡率差异均有统计学意义(P<0.05)。
4.对照组中可以见到细胞质中较多的Survivin蛋白和Bcl-2蛋白表达,呈浅黄色到棕黄色颗粒。ATRA组和L-OHP组阳性表达细胞数减少,而联合用药组的细胞表达数更少。联合用药组与ATRA组、L-OHP组相比,蛋白阳性率差异均有统计学意义(P<0.05)。
1. ATRA对人胃癌BGC-823细胞存在增殖抑制作用,且具有时间依赖性,最佳作用时间为48h,与L-OHP联用后对BGC-823细胞的增殖抑制作用更显著。
2. ATRA可诱导人胃癌BGC-823细胞分化,形成G0/G1期阻滞；L-OHP可促进细胞凋亡,形成G2/M期和S期阻滞。两者联用可发挥协同作用,加强对BGC-823细胞凋亡的促进作用。
3. ATRA与L-OHP可诱导人胃癌BGC-823细胞凋亡,机制可能与下调Bcl-2蛋白和Survivin蛋白的表达有关。
Gastric cancer is a common malignancy worldwide, accounts for the forth most common malignant tumors and the first two of the total cancer death rate. In our country,the incidence and mortality of gastric cancer account for the first 1 and 3 respectly. Medicines for the treatment of gastric cancer emerging in the short term showed good clinical efficacy. However, large-scale follow-up show that long-term survival of cancer patients has not increased significantly as the use of chemotherapy and serious side effects of some chemotherapy drugs limit their clinical application. Low-dose and multi-drug combinatioand is an important cancer drug research direction.
All-trans retinoic acid (all-trans retinoic acid, ATRA) is the major metabolite of vitamin A,and is essential to maintain growth and development.It is a recognized differentiation inducer. Oxaliplatin (Oxaliplatin, L-OHP) is the third generation platinum anti-cancer compounds, mainly used for advanced colorectal cancer. It has no cross-resistance with the first generation cisplatin and the second generation carboplatin and its good tolerance, low toxicity, therefore it is recognized.
Whether ATRA combined with L-OHP used in gastric cancer can increase efficacy has currently not reported. In this study, we observe the induction of apoptosis of retinoic acid (ATRA) comibined with oxaliplatin (L-OHP) in human gastric cancer BGC-823 cells in vitro observation of cellular, thus provide a theoretical basis for further study.
1. Treat BGC-823 cells with ATRA、L-OHP respectively and then combined, observe the morphologieal changes of BGC-823 cells by inverted microscope.
2. Assesse the proliferative inhibition rate of BGC-823 cells after treated with ATRA and L-OHP respectively for 24h,48h,72h by MTT assay.
3. Analyze the changes of apoptosis rate and cell cycle of BGC-823 cells after treated with ATRA and L-OHP for 48h by flow cytometry(FCM).
4. Detect the expressions of Bcl-2 and Survivin protein of BGC-823 cells after treated with ATRA and L-OHP for 48h by immunohistochemistry method.
1.24h after treated with drugs, cell gaps widened, intracellular granules increased and became vacuoles.48h later,most of cells floated in the culture medium and few cells still shew adherent growth. The nucleus in some cells were pyknosis and broken.The nuclear membrane disappeard but the cell membrane kept integrity and grew apophysises.All of the changes shew the advanced stage of apoptotisis.72h later, the number of apoptotic cells increased.Compared with the control group,more cells became debris and the number of adherent cells reduced significantly in experimental groups.
2. The proliferative inhibition effect of the cells treated with ATRA shew time dependence and the effect was not obvious at 24h.48h and 72h later,the effect was relatively obvious.Compared with the control group,the difference was statistically significant(P<0.05).The inhibition effect was more significant in the combined group. The best time of action was 48h.Compared with the ATRA group and L-OHP group,the difference was statistically significant(P<0.05).
3.48h after treated with ATRA, the rate of G0/G1 and G2/M phase cellls increased and the rate of S phase decreased. After treated with L-OHP, the rate of G0/G1 phase declined, while phase S and G2/M increased.In the combined group, the rate of G0/G1 phase and G2/M phase cells increased and S phase decreased. The differences of the apoptosis rate among the three groups was statistically significant(P<0.05).
4. Among the four groups,the expression of Survivin protein and Bcl-2 protein in cytoplasm were the most in the control group and the least in the combined group.The differences of the positive rate among the four groups was statistically significant (P<0.05).
1. ATRA could inhibit the proliferation of human gastric cancer BGC-823 cells and the effect shew time dependence.The best results appeared at 48h. Associated with L-OHP, the proliferative inhibition effect of the cells reinforced.
2. ATRA could induce the differentiation of human gastric cancer BGC-823 cells and arouse G0/G1 phase arrest.L-OHP could promote cell apoptosis and arouse G2/M phase and S phase arrest.The effect of inducing apoptosis were enhanced when ATRA and L-OHP were combined.
3. ATRA and L-OHP could induce the apoptosis of human gastric cancer BGC-823 cells and the probable mechanism might be related to the down regulation of the expression of Bcl-2 and Survivin protein.
引文
[1]Catalano V, Labianca R, Beretta GD, et al.Gastric cancer[J].Crit Rev Oncol Hematol,2009,71 (2):127-164.
[2]孙燕,石远凯.临床肿瘤内科手册(第5版)[M],北京：人民卫生出版社,2007.476-477.
[3]Ohtsu A.Chemotherapy for metastatic gastric cancer:past, present,and future[J]. Gastroenterol,2008,43(4):256-264.
[4]Moehler M, Galle PR, Gockel I, et al.The multidisciplinary management of gastrointestinal cancer[J].Best Pract Res Clin Gastroenterol,2007,21(6):965-981.
[5]郝北辰,张奕华.具有抗肿瘤作用的维甲酸类化合物的研究进展[J].药学进展,2006,30(2)：65-69.
[6]Wang ZY,Chen Z.Differentiation and apoptosis induction therapy in acute promyelocytic leukemia[J].Lancet Oncology,2000,1:101-106.
[7]陈竺,孙关林,王振义等.全反式维A酸诱导分化治疗急性早幼粒细胞白血病的机制研究[J].上海第二医科大学学报,2002,22(5)：1-4.
[8]路太英,樊青霞,王留兴等.全反式维甲酸诱导食管癌细胞凋亡的实验研究[J].中华肿瘤杂志,2007,29(11)：822-825.
[9]路太英,樊青霞,杨成梁等.全反式维甲酸对EC9706荷瘤裸鼠抑瘤作用的实验研究[J].肿瘤,2007,27(8)：599-601.
[10]Clerici C,Castellani D,Russo G,et al.Treatment with all-trans retinoic acid plus tamoxifen and vitamin E in advanced hepatocellular carcinoma[J].Anticancer Res,2004,24(2C):1255-1260.
[11]杨松海,全红,杨捷.全反式维甲酸诱导肝癌细胞SNU-398表达nm23-H1[J]现代消化及介入诊疗,2009,14(4)：219-222.
[12]徐鉷,张志培,高坤祥等.全反式维甲酸对人肺癌细胞诱导凋亡的作用[J].现代肿瘤医学,2009,17(6)：1027-1029.
[13]Choi EJ, Whang YM, Kim SJ,et al. Combinational treatment with retinoic acid derivatives in non-small cell lung carcinoma in vitro [J].J Korean Med Sci,2007,22(Suppl):S52-60.
[14]殷平,王效民,王斌等.全反式维甲酸对结肠癌不同增殖潜能细胞株VEGF表达的影响[J].中国病理生理杂志,2006,22(11)：2198-2201.
[15]傅宏亮,王辉,李佳宁等.全反式维甲酸对乳腺癌MCF-7细胞增殖的影响[J].放射免疫学杂志,2007,20(5)：454-456.
[16]Yuan GB,Kuang AR,Fan Q,et al.Combined effects of all-trans-retinoic acid and trichostatin A on the induction of differentiation of thyroid carcinoma cells[J].Ai Zheng,2010,29(4):379-384.
[17]Ciarcia R,Pagnini C,Fiorito F,et al. Effect of All-trans retinoic acid in canine osteosarcoma chemotherapy[J].Vet Res Commun,2008,32(Suppl 1):S267-269.
[18]杨敏,赵涌,林晓等.全反式维甲酸对人卵巢癌细胞株COC1增殖分化的影响[J].重庆医科大学学报,2005,30(1)：12-15.
[19]Kucukzeybek Y,Gul MK,Cengiz E,et al.Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone-and drug resistant prostate cancer cell line,DU-145[J].J Exp Clin Cancer Res,2008,12(27):37.
[20]Temmink OH,Hoebe EK,van der Born K,et al. Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells[J].Br J Cancer,2007,96(2):231-240.
[21]Noordhuis P,Laan AC,van de Born K,et al.Oxaliplatin activity in selected and unselected human ovarian and colorectal cancer cell lines[J].Biochem Pharmacol,2008,76(1):53-61.
[22]Todd RC,Lippard SJ. Inhibition of transcription by platinum antitumor compounds [J]. Metallomics,2009,1 (4):280-291.
[23]Montopoli M,Ragazzi E,Froldi G.Cell-cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells[J].Cell Prolif,2009,42(2): 195-206.
[24]Raez LE,Kobina S,Santos ES.Oxaliplatin in first-line therapy for advanced non-small-cell lung cancer[J].Clin Lung Cancer,2010,11(1):18-24.
[25]Cortinovis D,Bidoli P,Zilembo N,et al.Oxaliplatin doublets in non-small cell lung cancer:a literature review[J].Lung Cancer,2008,60(3):325-331.
[26]Zhang L,Zhao C,Peng PJ,et al.Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma:preliminary results[J]. J Clin Oncol,2005,23(33):8461-8468.
[27]Field K,Michael M,Leong T.Locally advanced and metastatic gastric cancencurrent management and new treatment developments[J].Drugs,2008,68(3):299-317.
[28]Zaniboni A,Meriggi F.The emerging role of oxaliplatin in the treatment of gastric cancer[J].J Chemother,2005,17(6):656-662.
[29]Boku N.Chemotherapy for metastatic gastric cancer in Japan[J].Int J Clin Oncol,2008,13 (6):483-487.
[30]Gonzalez-Estevez C,Salo E.Autophagy and apoptosis in planarians[J].Apoptosis,2010,15(3): 279-292.
[31]Qing Chang,Zhengshan Chen,Jiangfeng You,et al.All-trans-retinoic acid induces cell growth arrest in a human medulloblastoma cell line [J].Journal of Neuro-Oncology,2007,84(3): 263-267.
[32]Jing Y,Hellinger N,Xia L,et al.Benzodithiophenes induce differentiation and apoptosis in human leukemia cells [J]. Cancer Res,2005,65(17):7847-7855.
[33]Love WK,Berletch JB,Andrews LG,et al.Epigenetic regulation of telomerase in retinoid-induced differentiation of human leukemia cells[J].Int J Oncol,2008,32(3):625-631.
[34]王爱丽,徐爱晖.维甲酸及其衍生物抗肺肿瘤作用的研究进展[J].临床肺科杂志,2009,14(1)：85-86.
[35]姚福生,詹杨,严红等.三氧化二砷联合全反式维甲酸治疗急性早幼粒细胞白血病29例[J]. 安徽医药,2008,12(10)：957-958.
[36]Kumar S, Khanduja KL, Verma N,et al.ATRA promotes alpha tocopherol succinate-induced apoptosis in freshly isolated leukemic cells from chronic myeloid leukemic patients[J].Mol Cell Biochem,2008,307(1-2):109-119.
[37]William-Faltaos S,Rouillard D,Lechat P,et al.Cell cycle arrest by oxaliplatin on cancer cells[J].Fundam Clin Pharmacol,2007,21(2):165-172.
[38]Rakitina TV,Vasilevskaya IA,O'Dwyer PJ.Inhibition of G1/S transition potentiates oxaliplatin-induced cell death in colon cancer cell lines[J].Biochem Pharmacol,2007,73(11):1715-1726.
[39]Cepeda V, Fuertes MA,Castilla J,Biochemical mechanisms of cisplatin cytotoxicity[J]. Anticancer Agents Med Chem,2007,7(1):3-18.
[40]Yang J,Parsons J,Nicolay NH,et al.Cells deficient in the base excision repair protein,DNA polymerase beta are hypersensitive to oxaliplatin chemotherapy[J].Oncogene,2010,29(3): 463-468.
[41]Wang A,Zeng R,Huang H.Retinoic acid and sodium butyrate as cell cycle regulators in the treatment of oral squamous carcinoma cells [J].Oncol Res,2008,17(4):175-182.
[42]Xie R,Medina R,Zhang Y,et al.The histone gene activator HINFP is a nonredundant cyclin E/CDK2 effector during early embryonic cell cycles[J].Proc Natl Acad Sci USA,2009,106 (30):12359-12364.
[43]Inui N,Sasaki S,Suda T,et al.The loss of retinoic acid receptor a,βand alcohol debydrogenase-3 expression in non-small cell lung cancer[J].Respirology,2003,8(3):302-309.
[44]Ran Zhang,Naren L.Banik,Swapan K.Ray.Combination of all-trans retinoic acid and interferon-gamma upregulated p27kipl and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells[J].Cancer Chemotherapy and Pharmacology,2008,62(3):407-416.
[45]杨平,曹杰,王辉等.奥沙利铂诱导结肠癌细胞株SW480凋亡过程中caspase-8的活化[J].广东医学,2007,28(3)：345-348.
[46]黄乔,胡国清.奥沙利铂对人低分化鼻咽癌细胞系CNE2体外增殖的影响[J].中国癌症杂志,2006,16(1)：42-48.
[47]Surajit Karmakar,Naren L. Banik,Sunil J. Patel,et al.Combination of all-trans retinoic acid and taxol regressed glioblastoma T98G xenografts in nude mice[J].Apoptosis,2007,12 (11):2077-2087.
[48]Peng Guo,Hai-jiao Chen,Qiu-yan Wang,et al.Down regulation of N-acetylglucosaminyl transferase V facilitates all-trans retinoic acid to induce apoptosis of human hepatocarcinoma cells [J].Molecular and Cellular Biochemistry,2006,284(1-2):103-110.
[49]骆霞岗,苗毅.全反式维甲酸对人胰腺癌细胞生长及Survivin基因表达的影响[J].南京医科大学学报(自然科学版),2006,26(06)：389-392.
[50]薛军,林茂芳.调控抗凋亡基因survivin表达的因素研究[J].中国实验血液学杂志,2005,13(6)：969-974.
[51]王恒兵,严春寅,陈卫国.全反式维甲酸对前列腺癌PC-3细胞Bcl-2、Bax表达的影响[J].苏州大学学报(医学版),2006,26(3)：447-449.
[52]樊代明.肿瘤研究前沿(第6卷)[M].西安：第四军医大学出版社,2007.77-78.
[53]Kleinberg L.Fl(?)renes VA,Nesland JM,et al.Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions[J].Am J Clin Pathol,2007,128 (3):389-397.
[54]Iskandar ZA, Al-Joudi FS.Expression of survivin in fetal and adult normal tissues of rat[J]. Malays J Pathol,2006,28(2):101-105.
[55]Yang X,Xiong G,Chen X,et al.Survivin expression in esophageal cancer:correlation with p53 mutations and promoter polymorphism[J].Dis Esophagus,2009,22(3):223-230.
[56]Krepela E,Dankova P,Moravcikova E,et al.Increased expression of inhibitor of apoptosis proteins, survivin and XIAP,in non-small cell lung carcinoma[J].Int J Oncol,2009,35(6): 1449-1462.
[57]Ranade KJ,Nerurkar AV,Phulpagar MD,et al.Expression of survivin and p53 proteins and their correlation with hormone receptor status in Indian breast cancer patients[J].Indian J Med Sci,2009,63(11):481-490.
[58]Kalliakmanis JQKouvidou C,Latoufis C,et al.Survivin Expression in Colorectal Carcinomas: Correlations with Clinicopathological Parameters and Survival[M]. Epub ahead of print:Dig Dis Sci,2009.24.
[59]Konduri S,Colon J,Baker CH,et al.Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression[J].Mol Cancer Ther,2009,8(3):533-542.
[60]Song KY,Jung CK,Park WS,et al.Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma [J].Jpn J Clin Oncol,2009,39(5):290-296.
[61]Ferrario A,Rucker N,Wong S,et al.Survivin,a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response[J].Cancer Res,2007,67(10):4989-4995.
[62]Croci DO,Cogno IS,Vittar NB,et al.Silencing survivin gene expression promotes apoptosis of human breast cancer cells through a caspase-independent pathway[J].J Cell Biochem,2008, 105(2):381-390.
[63]Amantini C,Mosca M,Lucciarini R,et al.Thiorphan-induced survival and proliferation of rat thymocytes by activation of Akt/survivin pathway and inhibition of caspase-3 activity[J].J Pharmacol Exp Ther,2008,327(1):215-225.
[64]Karna P,Sharp SM,Yates C,et al.EM011 activates a survivin-dependent apoptotic program in human non-small cell lung cancer cells[J].Mol Cancer,2009,30(8):93.
[65]樊代明.肿瘤研究前沿(第6卷)[M].西安：第四军医大学出版社,2007.53-54.
[66]Gonzalez LE,Juknat AA,Venosa AJ,et al.Manganese activates the mitochondrial apoptotic pathway in rat astrocytes by modulating the expression of proteins of the Bcl-2 family[J]. Neurochem Int,2008,53(6-8):408-415.
[67]Chipuk JE,Moldoveanu T,Llambi F,et al.The BCL-2 family reunion[J].Mol Cell,2010,37(3): 299-310.
[68]Kim K,Chie EK,Han W,et al.Prognostic value of p53 and bcl-2 expression in patients treated with breast conservative therapy[J]. J Korean Med Sci,2010,25(2):235-239.
[69]Smith AJ,Karpova Y,D'Agostino R Jr,et al.Expression of the Bcl-2 protein BAD promotes prostate cancer growth[J].PLoS One,2009,4(7):e6224.
[70]Poincloux L,Durando X,Seitz JF,et al.Loss of Bcl-2 expression in colon cancer:a prognostic factor for recurrence in stage II colon cancer[J].Surg Oncol,2009,18(4):357-365.
[71]Han ME,Lee YS,Baek SY,et al.Hedgehog signaling regulates the survival of gastric cancer cells by regulating the expression of bcl-2[J].Int J Mol Sci,2009,10(7):3033-3043.
[72]Renouf DJ, Wood-Baker R, Ionescu DN,et al.BCL-2 expression is prognostic for improved survival in non-small cell lung cancer[J].J Thorac Oncol,2009,4(4):486-491.
[73]Ide M,Fukushima N,Hisatomi T,et al.Non-germinal cell phenotype and bcl-2 expression in primary adrenal diffuse large B-cell lymphoma[J]. Leuk Lymphoma,2007,48(11):2244-2246.
[74]Hsu LJ,Hong Q,Schultz L,et al.Zfra is an inhibitor of Bcl-2 expression and cytochrome c release from the mitochondria[J].Cell Signal,2008,20(7):1303-1312.
[75]Handayani T,Sakinah S,Nallappan M,et al.Regulation of p53-,Bcl-2-and caspase-dependent signaling pathway in xanthorrhizol-induced apoptosis of HepG2 hepatoma cells[J]. Anticancer Res,2007,27(2):965-971.
[76]樊代明.肿瘤研究前沿(第6卷)[M].西安：第四军医大学出版社,2007.47-49
[77]刁连君.三氧化二砷与维甲酸双诱导序贯治疗急性早幼粒细胞白血病远期疗效以及不良反应观察[J].实用医技杂志,2008,15(29)：7114.
[78]王艳.全反式维甲酸治疗急性早幼粒细胞白血病毒副反应的观察和护理[J].常州实用医学,2009,25(1)：52-53.
[1]张静,霍满鹏,徐文梅等.肿瘤的分子遗传学基础及其应用[J].延安大学学报(医学科学版),2005,3(4)：8-11.
[2]管梅,陈书长.化疗和靶向治疗药物的常见神经毒副作用及其对策[J].癌症进展杂志,2009,7(1)：12-18.
[3]Rademake-Lakhai JM,Crul M,Zuur L,etal.Relationship between Cis Platin administration and the development of ototoxieity[J].J Clin oncol,2006,24:918.
[4]Gonzalez-Estevez C,Salo E.Autophagy and apoptosis in planarians[J].Apoptosis,2010,15 (3):279-292.
[5]刘正会.肿瘤诱导分化治疗的现状[J].现代医药卫生,2008,24(20)：3094-3095.
[6]郝北辰,张奕华.具有抗肿瘤作用的维甲酸类化合物的研究进展[J].药学进展,2006,30(2)：65-69.
[7]王爱丽,徐爱晖.维甲酸及其衍生物抗肺肿瘤作用的研究进展[J].临床肺科杂志,2009,14(1)：85-86.
[8]黄鑫,邓述恺.全反式维甲酸抗肿瘤机制的研究进展[J].山东医药,2008,48(45)：109-110.
[9]影近弘之.维甲酸类—癌症治疗与预防药物[J].日本医学介绍,2006,27(1)：32-34.
[10]Surender Kumar,Krishan Lal Khanduja,Neelam Verma,et al.ATRA promotesalpha tocophe-rol succinate-induced apoptosis in freshly isolated leukemic cells from chronic myeloid leukemic patients[J].Molecular and Cellular Biochemistry,2008,307(1-2):109-119.
[11]闫晓婷,史素芳.全反式维甲酸(ATRA)联合柔红霉素与阿糖胞苷对高细胞急性早幼粒细胞白血病(APL)的疗效[J].现代肿瘤医学,2009,17(2)：328-329.
[12]David Grimwade,Anita R.Mistry,Ellen Solomon.Acute Promyelocytic Leukemia:A Paradi-gm for Differentiation Therapy[J].Cancer Treatment and Research,2010,145:219-235.
[13]由蕾,严煜林.维甲酸类化合物及其受体与银屑病研究进展[J].医学综述,2007,13(6)：466-467.
[14]彭彦孟,彭家和,周度金等.视黄醇结合蛋白的研究进展[J].国际检验医学杂志,2007,28(8)：736-740.
[15]陈睿博,欧阳仁荣.维甲酸类化合物和维甲酸受体功能研究进展[J].山西医药杂志2000,29(4)：319-322.
[16]黄鑫,邓述恺.全反式维甲酸抗肿瘤机制的研究进展[J].山东医药,2008,48(45)：109-110.
[17]Li G,Yin W,Chamberlain R.Identification and characterization of the human retinoid X receptor alpha gene promoter[J].Gene,2006,372:118-127.
[18]Dolle P.Developmental expression of retinoic acid receptors (RARs)[J].Nucl Recept Signal,2009,7:e006.
[19]綦斌,罗毅男,田宇.维甲酸在抗肿瘤过程中信号传导途径[M].中国实验诊断学,2006,10(4)：439-441.
[20]Dillard AC,Lane MA.Retinol Increases beta-catenin-RXRalpha binding leading to the increased proteasomal degradation of beta-catenin and RXRalpha[J].Nutr Cancer,2008, 60(1):97-108.
[21]曲晓红.急性白血病化疗32例临床护理[J].齐鲁护理杂志,2008,14(23)：37-38.
[22]王金梅,杨艳红,崔文华等.急性早幼粒细胞白血病合并弥散性血管内凝血临床观察[J].基层医学论坛,2008,12：608.
[23]丁现超,王升,李新刚等.全反式维甲酸对急性早幼粒细胞白血病出凝血及纤溶指标的影响[J].中国药物与临床,2006,6(11)：868-869.
[24]Wang ZY,Chen Z.Differentiation and apoptosis induction therapy in acute promyelocytic leukemia[J].Lancet Oncology,2000,1:101-106.
[25]陈竺,孙关林,王振义等.全反式维A酸诱导分化治疗急性早幼粒细胞白血病的机制研究[J].上海第二医科大学学报,2002,22(5)：1-4.
[26]WangZY,Sun GL,Shen ZX,et al.Differentiation therapy for acute promye-locytic leukemia with all-trans retinoic acid:10-year experience of its clinical application[J].Chin Med J,1999, 112:963-967.
[27]Kapil Mehta, Robert K.Oldham, Bulent Ozpolat. Growth and differentiation factors as cancer therapeutics[M].Springer Netherlands,2009:527-568.
[28]冯雅青,贺永春,张利东等.全反式维甲酸联合亚砷酸诱导治疗急性早幼粒细胞白血病凝血及纤溶指标改变的初步研究[J].肿瘤研究与临床,2008,20(12)：823-825.
[29]尤学芬,丁润生,谢玉娟等.全反式维甲酸与紫杉醇、阿霉素联合诱导HL-60细胞凋亡的研究[J].陕西医学杂志,2007,36(7)：791-794.
[30]姚福生,詹杨,严红等.三氧化二砷联合全反式维甲酸治疗急性早幼粒细胞白血病29例[J].安徽医药,2008,12(10)：957-958.
[31]路太英,樊青霞,王留兴等.全反式维甲酸诱导食管癌细胞凋亡的实验研究[J].中华肿瘤杂志,2007,29(11)：822-825.
[32]路太英,樊青霞,杨成梁等.全反式维甲酸对EC9706荷瘤裸鼠抑瘤作用的实验研究[J].肿瘤,2007,27(8)：599-601.
[33]杨松海,全红,杨捷.全反式维甲酸诱导肝癌细胞SNU-398表达nm23-H1[J]现代消化及介入诊疗,2009,14(4)：219-222.
[34]方建林,冯敢生,陶红芳等.全反式维甲酸对Walker-256肝癌细胞分化及凋亡的诱导作用[J].世界华人消化杂志,2008,16(26)：2929-2934.
[35]Clerici C,Castellani D,Russo G,et al.Treatment with all-trans retinoic acid plus tamoxifen and vitamin E in advanced hepatocellular carcinoma[J].Anticancer Res,2004,24(2C):1255-1260.
[36]Komi Y,Sogabe Y,Ishibashi N,et al.Acyclic retinoid inhibits angiogenesis by suppressing the MAPKpathway[J].Lab Invest,2010,90(1):52-60.
[37]朱颖,章永平,张学军等.全反式维甲酸对多种胰腺癌细胞的诱导凋亡作用[J].胰腺病学,2007,7(1)：24-27.
[38]朱颖,章永平,袁耀宗.全反式维甲酸对胰腺癌裸鼠移植瘤的生长抑制作用[J].上海交通 大学学报(医学版),2006,26(10)：1154-1157.
[39]倪晓凌,许雪峰,楼文晖等.全反式维甲酸和三氧化二砷协同诱导胰腺癌细胞凋亡[J].中华实验外科杂志,2007,24(11)：1341-1342.
[40]殷平,王效民,王斌等.全反式维甲酸对结肠癌不同增殖潜能细胞株VEGF表达的影响[J].中国病理生理杂志,2006,22(11)：2198-2201.
[41]Kim SW,Hong JS,Ryu SH,et al.Regulation of mucin gene expression by CREB via a nonclassical retinoic acid signaling pathway[J].Mol Cell Biol,2007,27(19):6933-6947.
[42]Kawakami S,Suzuki S,Yamashita F,et al.Induction of apoptosis in A549 human lung cancer cells by all-trans retinoic acid incorporated in DOTAP/cholesterol liposomes[J].J Control Release,2006,110(3):514-521.
[43]Dragnev KH,Feng Q,Ma Y,et al.Uncovering novel targets for cancer chemoprevention[J]. Recent Results Cancer Res,2007,174:235-243.
[44]刘波,王志新,欧阳一辛.丁酸、全反式维甲酸对肺腺癌细胞株A549p-连环素、c-myc表达的影响[J].现代生物医学进展,2007,7(6)：840-845.
[45]LI YJ,WEI ZM,MENG YX,et al.Beta-catenin upregulates the expression of cyclinDl, c-myc and MMP-7 in human pancreatic cancer:relationships with carcinogenesis and metastasis [J].World J, Gastroentero 1,2005,11:2117-2123.
[46]张怀岭,范建新,单长波等.肺癌原代细胞耐药基因的表达和化疗敏感性的研究[J].中国现代医生,2008,46(20)：27-30.
[47]王凯,赵丽敏,陈献亮.联合应用全反式维甲酸和化疗药物对肺腺癌细胞株A549细胞的作用[J].中原医刊,2006,33(5)：1-3.
[48]曾艳,袁静萍,毛永荣等.维甲酸对A549细胞增殖和凋亡及Skp2、p27蛋白表达的影响[J].中国组织化学与细胞化学杂志,2009,18(3)：322-327.
[49]王渝东.全反式维甲酸对小细胞肺癌细胞的分化诱导作用研究[J].中国医药指南,2008,6(14)：33-34.
[50]Jiang M,Zhu K,Grenet J,et al.Retinoic acid induces caspase-8 transcription via phospho-CREB and increases apoptotic responses to death stimuli in neuroblastoma cells [J]. Biochim Biophys Acta,2008,1783(6):1055-1067.
[51]李男,张秀梅,王新等.维甲酸对甲状腺鳞癌细胞株SW579细胞增殖的影响[J].辽宁医学院学报,2008,29(1)：13-15.
[52]张秀梅,肖建英,孙靖靖等.全反式维甲酸对甲状腺鳞癌细胞株SW579凋亡的影响[J].锦州医学院学报,2006,27(06)：5-7.
[53]Toma S, Raffo P, Nicolo G,et al.Biological activity of all-trans-retinoic acid with and without tamoxifen and alpha-interferon 2a in breast cancer patients[J].Int J Oncol,2000, 17(5):991-1000.
[54]姚允怡,雷初朝,杨国栋等.全反式维甲酸对乳腺癌MCF-7细胞周期和增殖活性的影响及restin基因表达的初步研究[J].西南国防医药,2006,16(3)：238-240.
[55]姚允怡,杨国栋,路凡等.全反式维甲酸对乳腺癌MCF-7细胞MAGE家族分子表达的影响[J].科学技术与工程,2006,6(10)：1348-1352.
[56]傅宏亮,王辉,李佳宁等.全反式维甲酸对乳腺癌MCF-7细胞增殖的影响[J].放射免疫学杂志,2007,20(5)：454-456.
[57]陈海蛟,王秋雁,张立等.全反式维甲酸诱导前列腺癌DU145细胞凋亡中caspase-3及其细胞骨架蛋白F-actin的变化[J].中华泌尿外科杂志,2006,27(Suppl)：73-75.
[58]Pasquali D, Rossi V, Bellastella G,et al.Natural and synthetic retinoids in prostate cancer[J]. Curr Pharm Des,2006,12(15):1923-1929.
[59]Sun M, Li H,Wei Q,et al.The synergistic effects of docetaxol and retinoic acid on prostate cancer cell line PC-3[J].Sichuan Da Xue Xue Bao Yi Xue Ban,2004,35(6):797-801.
[60]陈卫国,严春寅,李纲等.全反式维甲酸对激素非依赖性前列腺癌连接蛋白43表达的影响[J].肿瘤,2007,27(3)：176-178.
[61]李扬,张萌,乔慧等.全反式维甲酸对骨肉瘤细胞0S732生长的影响[J].中国现代医学杂志,2005,15,(15)：2271-2274.
[62]袁林,郭风劲,陈安民.全反式维甲酸对人骨肉瘤细胞凋亡的诱导作用[J].华中科技大学学报(医学版),2007,36(1)：60-62.
[63]张岩,姜侃,夏仁云.全反式维甲酸体外诱导分化对人骨肉瘤MG-63细胞侵袭转移的影响[J].华中科技大学学报(医学版),2006,35(5)：613-616.
[64]杨敏,赵涌,林晓等.全反式维甲酸对人卵巢癌细胞株COC1增殖分化的影响[J].重庆医科大学学报,2005,30(1)：12-15.
[65]王承龙,赵素萍,肖建云等.全反式维甲酸诱导喉癌细胞凋亡的实验研究[J].中国耳鼻咽喉颅底外科杂志,2007,13(2)：94-98.
[66]岳丹,王勇等.全反式维甲酸诱导人膀胱癌EJ细胞凋亡的研究[J].中国医师进修杂志,2007,30(4B)：31-33.
[67]胡海燕,杨尚武,徐瑾.全反式维甲酸对宫颈癌细胞的生物学作用[J].海南医学院学报,2008,14(1)：12-15.
[68]Wang WJ, Tang W, Qiu ZY. Comparative proteomics analysis on differentiation of human promyelocytic leukemia HL-60 cells into granulocyte and monocyte lineages[J].Ai Zheng, 2009,28(2):117-121.
[69]Yuan GB,Kuang AR,Fan Q,et al.Combined effects of all-trans-retinoic acid and trichostatin A on the induction of differentiation of thyroid carcinoma cells[J].Ai Zheng,2010,29(4): 379-384.
[70]Liu J,Bi G,Wen P,et al.Down-regulation of CD44 contributes to the differentiation of HL-60 cells induced by ATRA or HMBA[J].Cell Mol Immunol,2007,4(1):59-63.
[71]Lin MF,Qian XJ.Effect of aminopeptidase inhibitor on differentiation induction activity of all-trans retinoic acid in human acute promyelocytic leukemia NB4 cells and its mechanism[J].Zhongguo Shi Yan Xue Ye Xue Za Zhi,2006,14(3):471-476.
[72]Jing Y, Hellinger N, Xia L,et al.Benzodithiophenes induce differentiation and apoptosis in human leukemia cells[J].Cancer Res,2005,65(17):7847-7855.
[73]Love WK,Berletch JB,Andrews LG,et al.Epigenetic regulation of telomerase in retinoid-induced differentiation of human leukemia cells[J].Int J Oncol,2008,32(3):625-631.
[74]Wang A,Zeng R,Huang H.Retinoic acid and sodium butyrate as cell cycle regulators in the treatment of oral squamous carcinoma cells[J].Oncol Res,2008,17(4):175-182.
[75]Xie R,Medina R,Zhang Y,et al.The histone gene activator HINFP is a nonredundant cyclin E/CDK2 effector during early embryonic cell cycles[J]. Proc Natl Acad Sci USA,2009,106 (30):12359-12364.
[76]樊代明.肿瘤研究前沿(第6卷)[M].西安：第四军医大学出版社,2007.126-133.
[77]Dragnev KH,Feng Q,Ma Y,et al.Uncovering novel targets for cancer chemoprevention[J]. Recent Results Cancer Res,2007,174:235-243.
[78]文若剑,谢大兴,龚建平CD11b/DNA双参数流式细胞术检测HL-60细胞分化的细胞周期[J].中国组织化学与细胞化学杂志,2006,15(4)：427-432.
[79]Kosaka C,Sasaguri T,Komiyama Y,et al.All-trans retinoic acid inhibits vascular smooth muscle cell proliferation targeting multiple genes for cyclins and cyclin-dependent kinases [J].Hypertens Res,2001,24(5):579-588.
[80]Schneider SM,Offterdinger M,Huber H,et al.Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells[J].Cancer Res,2000,60(19):5479-5487.
[81]Ran Zhang,Naren L.Banik,Swapan K.Ray.Combination of all-trans retinoic acid and interferon-gamma upregulated p27klpl and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells[J].Cancer Chemotherapy and Pharmacology,2008, 62(3):407-416.
[82]周人杰,廖卫公,闵家新等ATRA对A549人肺腺癌细胞株增殖、细胞周期的影响及其机制研究[J].第三军医大学学报,2007,29(14)：1399-1401.
[83]Meinel FG,Mandl-Weber S,Baumann p,et al.The novel,proteasome-independent NF-kappaB inhibitor V1810 induces apoptosis and cell cycle arrest in multiple myeloma and overcomes NF-kappaB-mediated drug resistance[J].Mol Cancer Ther,2010,9(2):300-310.
[84]Song L,Dong W,Gao M,et al.A novel role of IKKalpha in the mediation of UVB-induced G0/G1 cell cycle arrest response by suppressing Cyclin D1 expression[J].Biochim Biophys Acta,2010,1803(2):323-332.
[85]Witzel II, Koh LF, Perkins ND.Regulation of cyclin D1 gene expression[J].Biochem Soc Trans,2010,38(Ptl):217-222.
[86]李四强,侯忠赤,宫超等.全反式维甲酸对HL-60细胞NF-kB、CyclinD1表达的影响[J].中国现代医学杂志,2006,16(02)：180-182.
[87]罗毅男,綦斌,田宇.全反式维甲酸对脑胶质瘤细胞Cyclin E、Caspase-3表达的影响[J].中华实验外科杂志,2006,23(6)：721-723.
[88]杨敏,赵涌.全反式维甲酸对人卵巢癌细胞cyclinD1和CDK4表达的影响[J].临床与实验病理学杂志,2004,20(3)：342-345.
[89]Hockenbery DM.Targeting mitochondria for cancer therapy [J].Environ Mol Mutagen,2010, Mar,8.
[90]Peng Guo,Hai-jiao Chen,Qiu-yan Wang,et al.Down regulation of N-acetylglucosaminyl-transferase V facilitates all-trans retinoic acid to induce apoptosis of human hepatocarcinoma cells[J]. Molecular and Cellular Biochemistry,2006,284(1-2):103-110.
[91]Surajit Karmakar,Naren L. Banik,Sunil J. Patel,et al.Combination of all-trans retinoic acid and taxol regressed glioblastoma T98G xenografts in nude mice[J].Apoptosis,2007,12(11): 2077-2087.
[92]骆霞岗,苗毅.全反式维甲酸对人胰腺癌细胞生长及Survivin基因表达的影响[J].南京医科大学学报(自然科学版),2006,26(06)：389-392.
[93]路太英,杨成梁,樊青霞等.全反式维甲酸对人食管癌细胞生长及survivin基因表达的影响[J].山东医药,2007,47(26)：30-32.
[94]Kleinberg L,Fl(?)renes VA,Nesland JM,et al. Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions [J]. Am J Clin Pathol,2007,128 (3):389-397.
[95]Iskandar ZA,Al-Joudi FS.Expression of survivin in fetal and adult normal tissues of rat[J].Malays J Pathol,2006,28(2):101-105.
[96]Amantini C,Mosca M,Lucciarini R,et al.Thiorphan-induced survival and proliferation of rat thymocytes by activation of Akt/survivin pathway and inhibition of caspase-3 activity[J].J Pharmacol Exp Ther,2008,327(1):215-225.
[97]Kama P,Sharp SM,Yates C,et al.EM011 activates a survivin-dependent apoptotic program in human non-small cell lung cancer cells[J]. Mol Cancer,2009,30(8):93.
[98]薛军,林茂芳.调控抗凋亡基因survivin表达的因素研究[J].中国实验血液学杂志,2005,13(6)：969-974.
[99]陈建丽,曹婷婷.全反式维甲酸对A549细胞株增殖和Caspase-3蛋白表达的影响[J].郑州大学学报(医学版),2007,42(3)：531-533.
[100]Huang H, Wu D,Fu J,et al.All-trans retinoic acid can intensify the growth inhibition and differentiation induction effect of rosiglitazone on multiple myeloma cells[J].Eur J Haematol,2009,83 (3):191-202.
[101]Meggiato T,Calabrese F,De Cesare CM,et al.C-JUN and CPP32 (caspase-3) in human pancreatic cancer:relation to cell proliferation and death [J].Pancreas.2003.26:65.
[102]王恒兵,严春寅,陈卫国.全反式维甲酸对前列腺癌PC-3细胞Bcl-2、Bax表达的影响[J].苏州大学学报(医学版),2006,26(3)：447-449.
[103]Gonzalez LE,Juknat AA,Venosa AJ,et al.Manganese activates the mitochondrial apoptotic pathway in rat astrocytes by modulating the expression of proteins of the Bcl-2 family[J]. Neurochem Int,2008,53(6-8):408-415.
[104]Chipuk JE,Moldoveanu T,Llambi F,et al.The BCL-2 family reunion[J]. Mol Cell,2010,37 (3):299-310.
[105]樊代明.肿瘤研究前沿(第6卷)[M].西安：第四军医大学出版社.2007.44-46.
[106]Li J,Orr B,White K,et al.Chmp 1A is a mediator of the anti-proliferative effects of all-trans retinoic acid in human pancreatic cancer cells[J].Mol Cancer,2009,12(8):7.
[107]Yamazaki K,Shimizu M,Okuno M,et al.Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells-phosphorylated RXR alpha is a critical target for colon cancer management[J].Gut,2007,56(11):1557-1563.
[108]K. L. Khanduja, S. Kumar, N. Varma,et al.Enhancement in alpha-tocopherol succinate-induced apoptosis by all-trans-retinoic acid in primary leukemic cells:role of antioxidant defense, Bax and c-myc[J].Molecular and Cellular Biochemistry,2008,319, (1-2):133-139.
[109]Das A,Banik NL,Ray SK.Retinoids induced astrocytic differentiation with down regulation of telomerase activity and enhanced sensitivity to taxol for apoptosis in human glioblastoma T98G and U87MG cells[J].J Neurooncol,2008,87(1):9-22.
[110]Fukushina I.Shinomuia N.Nakamuia K.et al.Demonstration of human telomerase reverse transcriptase by in situ hybridization in lung carcinoma[J].Oncol Rep,2004,12(6):1227-1232.
[111]高兴成,黄伟佳,汪中扬等.端粒酶活性与膀胱肿瘤T24细胞的诱导分化研究[J].中华实验外科杂志,2002,19(6)：499-500.
[112]Kini AR,Peterson LA,Tallman MS,et al.Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid[J]. Blood,2001,97(12):3919-3924.
[113]马建刚,李晓明,蒋新霞等.乙酰肝素酶和VEGF在头颈鳞癌组织中的表达及其临床意义[J].中国肿瘤临床,2008,35(1)：31-35.
[114]Gee MF,Tsuchida R,Eichler-Jonsson C,et al.Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid[J].Oncogene,2005 Dec 1;24(54):8025-8037.
[115]刁连君.三氧化二砷与维甲酸双诱导序贯治疗急性早幼粒细胞白血病远期疗效以及不良反应观察[J].实用医技杂志,2008,15,(29)：4117.
[116]王艳.全反式维甲酸治疗急性早幼粒细胞白血病毒副反应的观察和护理[J].常州实用医学,2009,25(1)：52-53.
[117]Okuno M,Kojima S,Matsushima-Nishiwaki R,et al.Rrtinoids in cancer chemoprevention [J].Curr Cancer Drug Targets,2004,4(3):285-298.
[118]郭玉霞,徐酉华.全反式维甲酸相关多药耐药机制及其逆转的研究进展[J].儿科药学杂志,2007,13(6)：54-57
[2]孙燕,石远凯.临床肿瘤内科手册(第5版)[M],北京：人民卫生出版社,2007.476-477.
[3]Ohtsu A.Chemotherapy for metastatic gastric cancer:past, present,and future[J]. Gastroenterol,2008,43(4):256-264.
[4]Moehler M, Galle PR, Gockel I, et al.The multidisciplinary management of gastrointestinal cancer[J].Best Pract Res Clin Gastroenterol,2007,21(6):965-981.
[5]郝北辰,张奕华.具有抗肿瘤作用的维甲酸类化合物的研究进展[J].药学进展,2006,30(2)：65-69.
[6]Wang ZY,Chen Z.Differentiation and apoptosis induction therapy in acute promyelocytic leukemia[J].Lancet Oncology,2000,1:101-106.
[7]陈竺,孙关林,王振义等.全反式维A酸诱导分化治疗急性早幼粒细胞白血病的机制研究[J].上海第二医科大学学报,2002,22(5)：1-4.
[8]路太英,樊青霞,王留兴等.全反式维甲酸诱导食管癌细胞凋亡的实验研究[J].中华肿瘤杂志,2007,29(11)：822-825.
[9]路太英,樊青霞,杨成梁等.全反式维甲酸对EC9706荷瘤裸鼠抑瘤作用的实验研究[J].肿瘤,2007,27(8)：599-601.
[10]Clerici C,Castellani D,Russo G,et al.Treatment with all-trans retinoic acid plus tamoxifen and vitamin E in advanced hepatocellular carcinoma[J].Anticancer Res,2004,24(2C):1255-1260.
[11]杨松海,全红,杨捷.全反式维甲酸诱导肝癌细胞SNU-398表达nm23-H1[J]现代消化及介入诊疗,2009,14(4)：219-222.
[12]徐鉷,张志培,高坤祥等.全反式维甲酸对人肺癌细胞诱导凋亡的作用[J].现代肿瘤医学,2009,17(6)：1027-1029.
[13]Choi EJ, Whang YM, Kim SJ,et al. Combinational treatment with retinoic acid derivatives in non-small cell lung carcinoma in vitro [J].J Korean Med Sci,2007,22(Suppl):S52-60.
[14]殷平,王效民,王斌等.全反式维甲酸对结肠癌不同增殖潜能细胞株VEGF表达的影响[J].中国病理生理杂志,2006,22(11)：2198-2201.
[15]傅宏亮,王辉,李佳宁等.全反式维甲酸对乳腺癌MCF-7细胞增殖的影响[J].放射免疫学杂志,2007,20(5)：454-456.
[16]Yuan GB,Kuang AR,Fan Q,et al.Combined effects of all-trans-retinoic acid and trichostatin A on the induction of differentiation of thyroid carcinoma cells[J].Ai Zheng,2010,29(4):379-384.
[17]Ciarcia R,Pagnini C,Fiorito F,et al. Effect of All-trans retinoic acid in canine osteosarcoma chemotherapy[J].Vet Res Commun,2008,32(Suppl 1):S267-269.
[18]杨敏,赵涌,林晓等.全反式维甲酸对人卵巢癌细胞株COC1增殖分化的影响[J].重庆医科大学学报,2005,30(1)：12-15.
[19]Kucukzeybek Y,Gul MK,Cengiz E,et al.Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone-and drug resistant prostate cancer cell line,DU-145[J].J Exp Clin Cancer Res,2008,12(27):37.
[20]Temmink OH,Hoebe EK,van der Born K,et al. Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells[J].Br J Cancer,2007,96(2):231-240.
[21]Noordhuis P,Laan AC,van de Born K,et al.Oxaliplatin activity in selected and unselected human ovarian and colorectal cancer cell lines[J].Biochem Pharmacol,2008,76(1):53-61.
[22]Todd RC,Lippard SJ. Inhibition of transcription by platinum antitumor compounds [J]. Metallomics,2009,1 (4):280-291.
[23]Montopoli M,Ragazzi E,Froldi G.Cell-cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells[J].Cell Prolif,2009,42(2): 195-206.
[24]Raez LE,Kobina S,Santos ES.Oxaliplatin in first-line therapy for advanced non-small-cell lung cancer[J].Clin Lung Cancer,2010,11(1):18-24.
[25]Cortinovis D,Bidoli P,Zilembo N,et al.Oxaliplatin doublets in non-small cell lung cancer:a literature review[J].Lung Cancer,2008,60(3):325-331.
[26]Zhang L,Zhao C,Peng PJ,et al.Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma:preliminary results[J]. J Clin Oncol,2005,23(33):8461-8468.
[27]Field K,Michael M,Leong T.Locally advanced and metastatic gastric cancencurrent management and new treatment developments[J].Drugs,2008,68(3):299-317.
[28]Zaniboni A,Meriggi F.The emerging role of oxaliplatin in the treatment of gastric cancer[J].J Chemother,2005,17(6):656-662.
[29]Boku N.Chemotherapy for metastatic gastric cancer in Japan[J].Int J Clin Oncol,2008,13 (6):483-487.
[30]Gonzalez-Estevez C,Salo E.Autophagy and apoptosis in planarians[J].Apoptosis,2010,15(3): 279-292.
[31]Qing Chang,Zhengshan Chen,Jiangfeng You,et al.All-trans-retinoic acid induces cell growth arrest in a human medulloblastoma cell line [J].Journal of Neuro-Oncology,2007,84(3): 263-267.
[32]Jing Y,Hellinger N,Xia L,et al.Benzodithiophenes induce differentiation and apoptosis in human leukemia cells [J]. Cancer Res,2005,65(17):7847-7855.
[33]Love WK,Berletch JB,Andrews LG,et al.Epigenetic regulation of telomerase in retinoid-induced differentiation of human leukemia cells[J].Int J Oncol,2008,32(3):625-631.
[34]王爱丽,徐爱晖.维甲酸及其衍生物抗肺肿瘤作用的研究进展[J].临床肺科杂志,2009,14(1)：85-86.
[35]姚福生,詹杨,严红等.三氧化二砷联合全反式维甲酸治疗急性早幼粒细胞白血病29例[J]. 安徽医药,2008,12(10)：957-958.
[36]Kumar S, Khanduja KL, Verma N,et al.ATRA promotes alpha tocopherol succinate-induced apoptosis in freshly isolated leukemic cells from chronic myeloid leukemic patients[J].Mol Cell Biochem,2008,307(1-2):109-119.
[37]William-Faltaos S,Rouillard D,Lechat P,et al.Cell cycle arrest by oxaliplatin on cancer cells[J].Fundam Clin Pharmacol,2007,21(2):165-172.
[38]Rakitina TV,Vasilevskaya IA,O'Dwyer PJ.Inhibition of G1/S transition potentiates oxaliplatin-induced cell death in colon cancer cell lines[J].Biochem Pharmacol,2007,73(11):1715-1726.
[39]Cepeda V, Fuertes MA,Castilla J,Biochemical mechanisms of cisplatin cytotoxicity[J]. Anticancer Agents Med Chem,2007,7(1):3-18.
[40]Yang J,Parsons J,Nicolay NH,et al.Cells deficient in the base excision repair protein,DNA polymerase beta are hypersensitive to oxaliplatin chemotherapy[J].Oncogene,2010,29(3): 463-468.
[41]Wang A,Zeng R,Huang H.Retinoic acid and sodium butyrate as cell cycle regulators in the treatment of oral squamous carcinoma cells [J].Oncol Res,2008,17(4):175-182.
[42]Xie R,Medina R,Zhang Y,et al.The histone gene activator HINFP is a nonredundant cyclin E/CDK2 effector during early embryonic cell cycles[J].Proc Natl Acad Sci USA,2009,106 (30):12359-12364.
[43]Inui N,Sasaki S,Suda T,et al.The loss of retinoic acid receptor a,βand alcohol debydrogenase-3 expression in non-small cell lung cancer[J].Respirology,2003,8(3):302-309.
[44]Ran Zhang,Naren L.Banik,Swapan K.Ray.Combination of all-trans retinoic acid and interferon-gamma upregulated p27kipl and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells[J].Cancer Chemotherapy and Pharmacology,2008,62(3):407-416.
[45]杨平,曹杰,王辉等.奥沙利铂诱导结肠癌细胞株SW480凋亡过程中caspase-8的活化[J].广东医学,2007,28(3)：345-348.
[46]黄乔,胡国清.奥沙利铂对人低分化鼻咽癌细胞系CNE2体外增殖的影响[J].中国癌症杂志,2006,16(1)：42-48.
[47]Surajit Karmakar,Naren L. Banik,Sunil J. Patel,et al.Combination of all-trans retinoic acid and taxol regressed glioblastoma T98G xenografts in nude mice[J].Apoptosis,2007,12 (11):2077-2087.
[48]Peng Guo,Hai-jiao Chen,Qiu-yan Wang,et al.Down regulation of N-acetylglucosaminyl transferase V facilitates all-trans retinoic acid to induce apoptosis of human hepatocarcinoma cells [J].Molecular and Cellular Biochemistry,2006,284(1-2):103-110.
[49]骆霞岗,苗毅.全反式维甲酸对人胰腺癌细胞生长及Survivin基因表达的影响[J].南京医科大学学报(自然科学版),2006,26(06)：389-392.
[50]薛军,林茂芳.调控抗凋亡基因survivin表达的因素研究[J].中国实验血液学杂志,2005,13(6)：969-974.
[51]王恒兵,严春寅,陈卫国.全反式维甲酸对前列腺癌PC-3细胞Bcl-2、Bax表达的影响[J].苏州大学学报(医学版),2006,26(3)：447-449.
[52]樊代明.肿瘤研究前沿(第6卷)[M].西安：第四军医大学出版社,2007.77-78.
[53]Kleinberg L.Fl(?)renes VA,Nesland JM,et al.Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions[J].Am J Clin Pathol,2007,128 (3):389-397.
[54]Iskandar ZA, Al-Joudi FS.Expression of survivin in fetal and adult normal tissues of rat[J]. Malays J Pathol,2006,28(2):101-105.
[55]Yang X,Xiong G,Chen X,et al.Survivin expression in esophageal cancer:correlation with p53 mutations and promoter polymorphism[J].Dis Esophagus,2009,22(3):223-230.
[56]Krepela E,Dankova P,Moravcikova E,et al.Increased expression of inhibitor of apoptosis proteins, survivin and XIAP,in non-small cell lung carcinoma[J].Int J Oncol,2009,35(6): 1449-1462.
[57]Ranade KJ,Nerurkar AV,Phulpagar MD,et al.Expression of survivin and p53 proteins and their correlation with hormone receptor status in Indian breast cancer patients[J].Indian J Med Sci,2009,63(11):481-490.
[58]Kalliakmanis JQKouvidou C,Latoufis C,et al.Survivin Expression in Colorectal Carcinomas: Correlations with Clinicopathological Parameters and Survival[M]. Epub ahead of print:Dig Dis Sci,2009.24.
[59]Konduri S,Colon J,Baker CH,et al.Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression[J].Mol Cancer Ther,2009,8(3):533-542.
[60]Song KY,Jung CK,Park WS,et al.Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma [J].Jpn J Clin Oncol,2009,39(5):290-296.
[61]Ferrario A,Rucker N,Wong S,et al.Survivin,a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response[J].Cancer Res,2007,67(10):4989-4995.
[62]Croci DO,Cogno IS,Vittar NB,et al.Silencing survivin gene expression promotes apoptosis of human breast cancer cells through a caspase-independent pathway[J].J Cell Biochem,2008, 105(2):381-390.
[63]Amantini C,Mosca M,Lucciarini R,et al.Thiorphan-induced survival and proliferation of rat thymocytes by activation of Akt/survivin pathway and inhibition of caspase-3 activity[J].J Pharmacol Exp Ther,2008,327(1):215-225.
[64]Karna P,Sharp SM,Yates C,et al.EM011 activates a survivin-dependent apoptotic program in human non-small cell lung cancer cells[J].Mol Cancer,2009,30(8):93.
[65]樊代明.肿瘤研究前沿(第6卷)[M].西安：第四军医大学出版社,2007.53-54.
[66]Gonzalez LE,Juknat AA,Venosa AJ,et al.Manganese activates the mitochondrial apoptotic pathway in rat astrocytes by modulating the expression of proteins of the Bcl-2 family[J]. Neurochem Int,2008,53(6-8):408-415.
[67]Chipuk JE,Moldoveanu T,Llambi F,et al.The BCL-2 family reunion[J].Mol Cell,2010,37(3): 299-310.
[68]Kim K,Chie EK,Han W,et al.Prognostic value of p53 and bcl-2 expression in patients treated with breast conservative therapy[J]. J Korean Med Sci,2010,25(2):235-239.
[69]Smith AJ,Karpova Y,D'Agostino R Jr,et al.Expression of the Bcl-2 protein BAD promotes prostate cancer growth[J].PLoS One,2009,4(7):e6224.
[70]Poincloux L,Durando X,Seitz JF,et al.Loss of Bcl-2 expression in colon cancer:a prognostic factor for recurrence in stage II colon cancer[J].Surg Oncol,2009,18(4):357-365.
[71]Han ME,Lee YS,Baek SY,et al.Hedgehog signaling regulates the survival of gastric cancer cells by regulating the expression of bcl-2[J].Int J Mol Sci,2009,10(7):3033-3043.
[72]Renouf DJ, Wood-Baker R, Ionescu DN,et al.BCL-2 expression is prognostic for improved survival in non-small cell lung cancer[J].J Thorac Oncol,2009,4(4):486-491.
[73]Ide M,Fukushima N,Hisatomi T,et al.Non-germinal cell phenotype and bcl-2 expression in primary adrenal diffuse large B-cell lymphoma[J]. Leuk Lymphoma,2007,48(11):2244-2246.
[74]Hsu LJ,Hong Q,Schultz L,et al.Zfra is an inhibitor of Bcl-2 expression and cytochrome c release from the mitochondria[J].Cell Signal,2008,20(7):1303-1312.
[75]Handayani T,Sakinah S,Nallappan M,et al.Regulation of p53-,Bcl-2-and caspase-dependent signaling pathway in xanthorrhizol-induced apoptosis of HepG2 hepatoma cells[J]. Anticancer Res,2007,27(2):965-971.
[76]樊代明.肿瘤研究前沿(第6卷)[M].西安：第四军医大学出版社,2007.47-49
[77]刁连君.三氧化二砷与维甲酸双诱导序贯治疗急性早幼粒细胞白血病远期疗效以及不良反应观察[J].实用医技杂志,2008,15(29)：7114.
[78]王艳.全反式维甲酸治疗急性早幼粒细胞白血病毒副反应的观察和护理[J].常州实用医学,2009,25(1)：52-53.
[1]张静,霍满鹏,徐文梅等.肿瘤的分子遗传学基础及其应用[J].延安大学学报(医学科学版),2005,3(4)：8-11.
[2]管梅,陈书长.化疗和靶向治疗药物的常见神经毒副作用及其对策[J].癌症进展杂志,2009,7(1)：12-18.
[3]Rademake-Lakhai JM,Crul M,Zuur L,etal.Relationship between Cis Platin administration and the development of ototoxieity[J].J Clin oncol,2006,24:918.
[4]Gonzalez-Estevez C,Salo E.Autophagy and apoptosis in planarians[J].Apoptosis,2010,15 (3):279-292.
[5]刘正会.肿瘤诱导分化治疗的现状[J].现代医药卫生,2008,24(20)：3094-3095.
[6]郝北辰,张奕华.具有抗肿瘤作用的维甲酸类化合物的研究进展[J].药学进展,2006,30(2)：65-69.
[7]王爱丽,徐爱晖.维甲酸及其衍生物抗肺肿瘤作用的研究进展[J].临床肺科杂志,2009,14(1)：85-86.
[8]黄鑫,邓述恺.全反式维甲酸抗肿瘤机制的研究进展[J].山东医药,2008,48(45)：109-110.
[9]影近弘之.维甲酸类—癌症治疗与预防药物[J].日本医学介绍,2006,27(1)：32-34.
[10]Surender Kumar,Krishan Lal Khanduja,Neelam Verma,et al.ATRA promotesalpha tocophe-rol succinate-induced apoptosis in freshly isolated leukemic cells from chronic myeloid leukemic patients[J].Molecular and Cellular Biochemistry,2008,307(1-2):109-119.
[11]闫晓婷,史素芳.全反式维甲酸(ATRA)联合柔红霉素与阿糖胞苷对高细胞急性早幼粒细胞白血病(APL)的疗效[J].现代肿瘤医学,2009,17(2)：328-329.
[12]David Grimwade,Anita R.Mistry,Ellen Solomon.Acute Promyelocytic Leukemia:A Paradi-gm for Differentiation Therapy[J].Cancer Treatment and Research,2010,145:219-235.
[13]由蕾,严煜林.维甲酸类化合物及其受体与银屑病研究进展[J].医学综述,2007,13(6)：466-467.
[14]彭彦孟,彭家和,周度金等.视黄醇结合蛋白的研究进展[J].国际检验医学杂志,2007,28(8)：736-740.
[15]陈睿博,欧阳仁荣.维甲酸类化合物和维甲酸受体功能研究进展[J].山西医药杂志2000,29(4)：319-322.
[16]黄鑫,邓述恺.全反式维甲酸抗肿瘤机制的研究进展[J].山东医药,2008,48(45)：109-110.
[17]Li G,Yin W,Chamberlain R.Identification and characterization of the human retinoid X receptor alpha gene promoter[J].Gene,2006,372:118-127.
[18]Dolle P.Developmental expression of retinoic acid receptors (RARs)[J].Nucl Recept Signal,2009,7:e006.
[19]綦斌,罗毅男,田宇.维甲酸在抗肿瘤过程中信号传导途径[M].中国实验诊断学,2006,10(4)：439-441.
[20]Dillard AC,Lane MA.Retinol Increases beta-catenin-RXRalpha binding leading to the increased proteasomal degradation of beta-catenin and RXRalpha[J].Nutr Cancer,2008, 60(1):97-108.
[21]曲晓红.急性白血病化疗32例临床护理[J].齐鲁护理杂志,2008,14(23)：37-38.
[22]王金梅,杨艳红,崔文华等.急性早幼粒细胞白血病合并弥散性血管内凝血临床观察[J].基层医学论坛,2008,12：608.
[23]丁现超,王升,李新刚等.全反式维甲酸对急性早幼粒细胞白血病出凝血及纤溶指标的影响[J].中国药物与临床,2006,6(11)：868-869.
[24]Wang ZY,Chen Z.Differentiation and apoptosis induction therapy in acute promyelocytic leukemia[J].Lancet Oncology,2000,1:101-106.
[25]陈竺,孙关林,王振义等.全反式维A酸诱导分化治疗急性早幼粒细胞白血病的机制研究[J].上海第二医科大学学报,2002,22(5)：1-4.
[26]WangZY,Sun GL,Shen ZX,et al.Differentiation therapy for acute promye-locytic leukemia with all-trans retinoic acid:10-year experience of its clinical application[J].Chin Med J,1999, 112:963-967.
[27]Kapil Mehta, Robert K.Oldham, Bulent Ozpolat. Growth and differentiation factors as cancer therapeutics[M].Springer Netherlands,2009:527-568.
[28]冯雅青,贺永春,张利东等.全反式维甲酸联合亚砷酸诱导治疗急性早幼粒细胞白血病凝血及纤溶指标改变的初步研究[J].肿瘤研究与临床,2008,20(12)：823-825.
[29]尤学芬,丁润生,谢玉娟等.全反式维甲酸与紫杉醇、阿霉素联合诱导HL-60细胞凋亡的研究[J].陕西医学杂志,2007,36(7)：791-794.
[30]姚福生,詹杨,严红等.三氧化二砷联合全反式维甲酸治疗急性早幼粒细胞白血病29例[J].安徽医药,2008,12(10)：957-958.
[31]路太英,樊青霞,王留兴等.全反式维甲酸诱导食管癌细胞凋亡的实验研究[J].中华肿瘤杂志,2007,29(11)：822-825.
[32]路太英,樊青霞,杨成梁等.全反式维甲酸对EC9706荷瘤裸鼠抑瘤作用的实验研究[J].肿瘤,2007,27(8)：599-601.
[33]杨松海,全红,杨捷.全反式维甲酸诱导肝癌细胞SNU-398表达nm23-H1[J]现代消化及介入诊疗,2009,14(4)：219-222.
[34]方建林,冯敢生,陶红芳等.全反式维甲酸对Walker-256肝癌细胞分化及凋亡的诱导作用[J].世界华人消化杂志,2008,16(26)：2929-2934.
[35]Clerici C,Castellani D,Russo G,et al.Treatment with all-trans retinoic acid plus tamoxifen and vitamin E in advanced hepatocellular carcinoma[J].Anticancer Res,2004,24(2C):1255-1260.
[36]Komi Y,Sogabe Y,Ishibashi N,et al.Acyclic retinoid inhibits angiogenesis by suppressing the MAPKpathway[J].Lab Invest,2010,90(1):52-60.
[37]朱颖,章永平,张学军等.全反式维甲酸对多种胰腺癌细胞的诱导凋亡作用[J].胰腺病学,2007,7(1)：24-27.
[38]朱颖,章永平,袁耀宗.全反式维甲酸对胰腺癌裸鼠移植瘤的生长抑制作用[J].上海交通 大学学报(医学版),2006,26(10)：1154-1157.
[39]倪晓凌,许雪峰,楼文晖等.全反式维甲酸和三氧化二砷协同诱导胰腺癌细胞凋亡[J].中华实验外科杂志,2007,24(11)：1341-1342.
[40]殷平,王效民,王斌等.全反式维甲酸对结肠癌不同增殖潜能细胞株VEGF表达的影响[J].中国病理生理杂志,2006,22(11)：2198-2201.
[41]Kim SW,Hong JS,Ryu SH,et al.Regulation of mucin gene expression by CREB via a nonclassical retinoic acid signaling pathway[J].Mol Cell Biol,2007,27(19):6933-6947.
[42]Kawakami S,Suzuki S,Yamashita F,et al.Induction of apoptosis in A549 human lung cancer cells by all-trans retinoic acid incorporated in DOTAP/cholesterol liposomes[J].J Control Release,2006,110(3):514-521.
[43]Dragnev KH,Feng Q,Ma Y,et al.Uncovering novel targets for cancer chemoprevention[J]. Recent Results Cancer Res,2007,174:235-243.
[44]刘波,王志新,欧阳一辛.丁酸、全反式维甲酸对肺腺癌细胞株A549p-连环素、c-myc表达的影响[J].现代生物医学进展,2007,7(6)：840-845.
[45]LI YJ,WEI ZM,MENG YX,et al.Beta-catenin upregulates the expression of cyclinDl, c-myc and MMP-7 in human pancreatic cancer:relationships with carcinogenesis and metastasis [J].World J, Gastroentero 1,2005,11:2117-2123.
[46]张怀岭,范建新,单长波等.肺癌原代细胞耐药基因的表达和化疗敏感性的研究[J].中国现代医生,2008,46(20)：27-30.
[47]王凯,赵丽敏,陈献亮.联合应用全反式维甲酸和化疗药物对肺腺癌细胞株A549细胞的作用[J].中原医刊,2006,33(5)：1-3.
[48]曾艳,袁静萍,毛永荣等.维甲酸对A549细胞增殖和凋亡及Skp2、p27蛋白表达的影响[J].中国组织化学与细胞化学杂志,2009,18(3)：322-327.
[49]王渝东.全反式维甲酸对小细胞肺癌细胞的分化诱导作用研究[J].中国医药指南,2008,6(14)：33-34.
[50]Jiang M,Zhu K,Grenet J,et al.Retinoic acid induces caspase-8 transcription via phospho-CREB and increases apoptotic responses to death stimuli in neuroblastoma cells [J]. Biochim Biophys Acta,2008,1783(6):1055-1067.
[51]李男,张秀梅,王新等.维甲酸对甲状腺鳞癌细胞株SW579细胞增殖的影响[J].辽宁医学院学报,2008,29(1)：13-15.
[52]张秀梅,肖建英,孙靖靖等.全反式维甲酸对甲状腺鳞癌细胞株SW579凋亡的影响[J].锦州医学院学报,2006,27(06)：5-7.
[53]Toma S, Raffo P, Nicolo G,et al.Biological activity of all-trans-retinoic acid with and without tamoxifen and alpha-interferon 2a in breast cancer patients[J].Int J Oncol,2000, 17(5):991-1000.
[54]姚允怡,雷初朝,杨国栋等.全反式维甲酸对乳腺癌MCF-7细胞周期和增殖活性的影响及restin基因表达的初步研究[J].西南国防医药,2006,16(3)：238-240.
[55]姚允怡,杨国栋,路凡等.全反式维甲酸对乳腺癌MCF-7细胞MAGE家族分子表达的影响[J].科学技术与工程,2006,6(10)：1348-1352.
[56]傅宏亮,王辉,李佳宁等.全反式维甲酸对乳腺癌MCF-7细胞增殖的影响[J].放射免疫学杂志,2007,20(5)：454-456.
[57]陈海蛟,王秋雁,张立等.全反式维甲酸诱导前列腺癌DU145细胞凋亡中caspase-3及其细胞骨架蛋白F-actin的变化[J].中华泌尿外科杂志,2006,27(Suppl)：73-75.
[58]Pasquali D, Rossi V, Bellastella G,et al.Natural and synthetic retinoids in prostate cancer[J]. Curr Pharm Des,2006,12(15):1923-1929.
[59]Sun M, Li H,Wei Q,et al.The synergistic effects of docetaxol and retinoic acid on prostate cancer cell line PC-3[J].Sichuan Da Xue Xue Bao Yi Xue Ban,2004,35(6):797-801.
[60]陈卫国,严春寅,李纲等.全反式维甲酸对激素非依赖性前列腺癌连接蛋白43表达的影响[J].肿瘤,2007,27(3)：176-178.
[61]李扬,张萌,乔慧等.全反式维甲酸对骨肉瘤细胞0S732生长的影响[J].中国现代医学杂志,2005,15,(15)：2271-2274.
[62]袁林,郭风劲,陈安民.全反式维甲酸对人骨肉瘤细胞凋亡的诱导作用[J].华中科技大学学报(医学版),2007,36(1)：60-62.
[63]张岩,姜侃,夏仁云.全反式维甲酸体外诱导分化对人骨肉瘤MG-63细胞侵袭转移的影响[J].华中科技大学学报(医学版),2006,35(5)：613-616.
[64]杨敏,赵涌,林晓等.全反式维甲酸对人卵巢癌细胞株COC1增殖分化的影响[J].重庆医科大学学报,2005,30(1)：12-15.
[65]王承龙,赵素萍,肖建云等.全反式维甲酸诱导喉癌细胞凋亡的实验研究[J].中国耳鼻咽喉颅底外科杂志,2007,13(2)：94-98.
[66]岳丹,王勇等.全反式维甲酸诱导人膀胱癌EJ细胞凋亡的研究[J].中国医师进修杂志,2007,30(4B)：31-33.
[67]胡海燕,杨尚武,徐瑾.全反式维甲酸对宫颈癌细胞的生物学作用[J].海南医学院学报,2008,14(1)：12-15.
[68]Wang WJ, Tang W, Qiu ZY. Comparative proteomics analysis on differentiation of human promyelocytic leukemia HL-60 cells into granulocyte and monocyte lineages[J].Ai Zheng, 2009,28(2):117-121.
[69]Yuan GB,Kuang AR,Fan Q,et al.Combined effects of all-trans-retinoic acid and trichostatin A on the induction of differentiation of thyroid carcinoma cells[J].Ai Zheng,2010,29(4): 379-384.
[70]Liu J,Bi G,Wen P,et al.Down-regulation of CD44 contributes to the differentiation of HL-60 cells induced by ATRA or HMBA[J].Cell Mol Immunol,2007,4(1):59-63.
[71]Lin MF,Qian XJ.Effect of aminopeptidase inhibitor on differentiation induction activity of all-trans retinoic acid in human acute promyelocytic leukemia NB4 cells and its mechanism[J].Zhongguo Shi Yan Xue Ye Xue Za Zhi,2006,14(3):471-476.
[72]Jing Y, Hellinger N, Xia L,et al.Benzodithiophenes induce differentiation and apoptosis in human leukemia cells[J].Cancer Res,2005,65(17):7847-7855.
[73]Love WK,Berletch JB,Andrews LG,et al.Epigenetic regulation of telomerase in retinoid-induced differentiation of human leukemia cells[J].Int J Oncol,2008,32(3):625-631.
[74]Wang A,Zeng R,Huang H.Retinoic acid and sodium butyrate as cell cycle regulators in the treatment of oral squamous carcinoma cells[J].Oncol Res,2008,17(4):175-182.
[75]Xie R,Medina R,Zhang Y,et al.The histone gene activator HINFP is a nonredundant cyclin E/CDK2 effector during early embryonic cell cycles[J]. Proc Natl Acad Sci USA,2009,106 (30):12359-12364.
[76]樊代明.肿瘤研究前沿(第6卷)[M].西安：第四军医大学出版社,2007.126-133.
[77]Dragnev KH,Feng Q,Ma Y,et al.Uncovering novel targets for cancer chemoprevention[J]. Recent Results Cancer Res,2007,174:235-243.
[78]文若剑,谢大兴,龚建平CD11b/DNA双参数流式细胞术检测HL-60细胞分化的细胞周期[J].中国组织化学与细胞化学杂志,2006,15(4)：427-432.
[79]Kosaka C,Sasaguri T,Komiyama Y,et al.All-trans retinoic acid inhibits vascular smooth muscle cell proliferation targeting multiple genes for cyclins and cyclin-dependent kinases [J].Hypertens Res,2001,24(5):579-588.
[80]Schneider SM,Offterdinger M,Huber H,et al.Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells[J].Cancer Res,2000,60(19):5479-5487.
[81]Ran Zhang,Naren L.Banik,Swapan K.Ray.Combination of all-trans retinoic acid and interferon-gamma upregulated p27klpl and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells[J].Cancer Chemotherapy and Pharmacology,2008, 62(3):407-416.
[82]周人杰,廖卫公,闵家新等ATRA对A549人肺腺癌细胞株增殖、细胞周期的影响及其机制研究[J].第三军医大学学报,2007,29(14)：1399-1401.
[83]Meinel FG,Mandl-Weber S,Baumann p,et al.The novel,proteasome-independent NF-kappaB inhibitor V1810 induces apoptosis and cell cycle arrest in multiple myeloma and overcomes NF-kappaB-mediated drug resistance[J].Mol Cancer Ther,2010,9(2):300-310.
[84]Song L,Dong W,Gao M,et al.A novel role of IKKalpha in the mediation of UVB-induced G0/G1 cell cycle arrest response by suppressing Cyclin D1 expression[J].Biochim Biophys Acta,2010,1803(2):323-332.
[85]Witzel II, Koh LF, Perkins ND.Regulation of cyclin D1 gene expression[J].Biochem Soc Trans,2010,38(Ptl):217-222.
[86]李四强,侯忠赤,宫超等.全反式维甲酸对HL-60细胞NF-kB、CyclinD1表达的影响[J].中国现代医学杂志,2006,16(02)：180-182.
[87]罗毅男,綦斌,田宇.全反式维甲酸对脑胶质瘤细胞Cyclin E、Caspase-3表达的影响[J].中华实验外科杂志,2006,23(6)：721-723.
[88]杨敏,赵涌.全反式维甲酸对人卵巢癌细胞cyclinD1和CDK4表达的影响[J].临床与实验病理学杂志,2004,20(3)：342-345.
[89]Hockenbery DM.Targeting mitochondria for cancer therapy [J].Environ Mol Mutagen,2010, Mar,8.
[90]Peng Guo,Hai-jiao Chen,Qiu-yan Wang,et al.Down regulation of N-acetylglucosaminyl-transferase V facilitates all-trans retinoic acid to induce apoptosis of human hepatocarcinoma cells[J]. Molecular and Cellular Biochemistry,2006,284(1-2):103-110.
[91]Surajit Karmakar,Naren L. Banik,Sunil J. Patel,et al.Combination of all-trans retinoic acid and taxol regressed glioblastoma T98G xenografts in nude mice[J].Apoptosis,2007,12(11): 2077-2087.
[92]骆霞岗,苗毅.全反式维甲酸对人胰腺癌细胞生长及Survivin基因表达的影响[J].南京医科大学学报(自然科学版),2006,26(06)：389-392.
[93]路太英,杨成梁,樊青霞等.全反式维甲酸对人食管癌细胞生长及survivin基因表达的影响[J].山东医药,2007,47(26)：30-32.
[94]Kleinberg L,Fl(?)renes VA,Nesland JM,et al. Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions [J]. Am J Clin Pathol,2007,128 (3):389-397.
[95]Iskandar ZA,Al-Joudi FS.Expression of survivin in fetal and adult normal tissues of rat[J].Malays J Pathol,2006,28(2):101-105.
[96]Amantini C,Mosca M,Lucciarini R,et al.Thiorphan-induced survival and proliferation of rat thymocytes by activation of Akt/survivin pathway and inhibition of caspase-3 activity[J].J Pharmacol Exp Ther,2008,327(1):215-225.
[97]Kama P,Sharp SM,Yates C,et al.EM011 activates a survivin-dependent apoptotic program in human non-small cell lung cancer cells[J]. Mol Cancer,2009,30(8):93.
[98]薛军,林茂芳.调控抗凋亡基因survivin表达的因素研究[J].中国实验血液学杂志,2005,13(6)：969-974.
[99]陈建丽,曹婷婷.全反式维甲酸对A549细胞株增殖和Caspase-3蛋白表达的影响[J].郑州大学学报(医学版),2007,42(3)：531-533.
[100]Huang H, Wu D,Fu J,et al.All-trans retinoic acid can intensify the growth inhibition and differentiation induction effect of rosiglitazone on multiple myeloma cells[J].Eur J Haematol,2009,83 (3):191-202.
[101]Meggiato T,Calabrese F,De Cesare CM,et al.C-JUN and CPP32 (caspase-3) in human pancreatic cancer:relation to cell proliferation and death [J].Pancreas.2003.26:65.
[102]王恒兵,严春寅,陈卫国.全反式维甲酸对前列腺癌PC-3细胞Bcl-2、Bax表达的影响[J].苏州大学学报(医学版),2006,26(3)：447-449.
[103]Gonzalez LE,Juknat AA,Venosa AJ,et al.Manganese activates the mitochondrial apoptotic pathway in rat astrocytes by modulating the expression of proteins of the Bcl-2 family[J]. Neurochem Int,2008,53(6-8):408-415.
[104]Chipuk JE,Moldoveanu T,Llambi F,et al.The BCL-2 family reunion[J]. Mol Cell,2010,37 (3):299-310.
[105]樊代明.肿瘤研究前沿(第6卷)[M].西安：第四军医大学出版社.2007.44-46.
[106]Li J,Orr B,White K,et al.Chmp 1A is a mediator of the anti-proliferative effects of all-trans retinoic acid in human pancreatic cancer cells[J].Mol Cancer,2009,12(8):7.
[107]Yamazaki K,Shimizu M,Okuno M,et al.Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells-phosphorylated RXR alpha is a critical target for colon cancer management[J].Gut,2007,56(11):1557-1563.
[108]K. L. Khanduja, S. Kumar, N. Varma,et al.Enhancement in alpha-tocopherol succinate-induced apoptosis by all-trans-retinoic acid in primary leukemic cells:role of antioxidant defense, Bax and c-myc[J].Molecular and Cellular Biochemistry,2008,319, (1-2):133-139.
[109]Das A,Banik NL,Ray SK.Retinoids induced astrocytic differentiation with down regulation of telomerase activity and enhanced sensitivity to taxol for apoptosis in human glioblastoma T98G and U87MG cells[J].J Neurooncol,2008,87(1):9-22.
[110]Fukushina I.Shinomuia N.Nakamuia K.et al.Demonstration of human telomerase reverse transcriptase by in situ hybridization in lung carcinoma[J].Oncol Rep,2004,12(6):1227-1232.
[111]高兴成,黄伟佳,汪中扬等.端粒酶活性与膀胱肿瘤T24细胞的诱导分化研究[J].中华实验外科杂志,2002,19(6)：499-500.
[112]Kini AR,Peterson LA,Tallman MS,et al.Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid[J]. Blood,2001,97(12):3919-3924.
[113]马建刚,李晓明,蒋新霞等.乙酰肝素酶和VEGF在头颈鳞癌组织中的表达及其临床意义[J].中国肿瘤临床,2008,35(1)：31-35.
[114]Gee MF,Tsuchida R,Eichler-Jonsson C,et al.Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid[J].Oncogene,2005 Dec 1;24(54):8025-8037.
[115]刁连君.三氧化二砷与维甲酸双诱导序贯治疗急性早幼粒细胞白血病远期疗效以及不良反应观察[J].实用医技杂志,2008,15,(29)：4117.
[116]王艳.全反式维甲酸治疗急性早幼粒细胞白血病毒副反应的观察和护理[J].常州实用医学,2009,25(1)：52-53.
[117]Okuno M,Kojima S,Matsushima-Nishiwaki R,et al.Rrtinoids in cancer chemoprevention [J].Curr Cancer Drug Targets,2004,4(3):285-298.
[118]郭玉霞,徐酉华.全反式维甲酸相关多药耐药机制及其逆转的研究进展[J].儿科药学杂志,2007,13(6)：54-57